Provided by Tiger Fintech (Singapore) Pte. Ltd.

SIGA Technologies Inc.

5.97
-0.0200-0.33%
Volume:430.21K
Turnover:2.56M
Market Cap:426.48M
PE:7.28
High:6.07
Open:5.99
Low:5.90
Close:5.99
Loading ...

Siga Technologies Inc. (SIGA) Outpaces Stock Market Gains: What You Should Know

Zacks
·
27 Feb

Siga Technologies Inc. (SIGA) Rises Higher Than Market: Key Facts

Zacks
·
20 Feb

Siga Technologies Inc. (SIGA) Stock Drops Despite Market Gains: Important Facts to Note

Zacks
·
12 Feb

Siga Technologies Inc. (SIGA) Laps the Stock Market: Here's Why

Zacks
·
05 Feb

Siga Technologies Inc. (SIGA) Registers a Bigger Fall Than the Market: Important Facts to Note

Zacks
·
28 Jan

Undiscovered Gems With Strong Fundamentals To Explore January 2025

Simply Wall St.
·
24 Jan

Siga Technologies Inc. (SIGA) Surpasses Market Returns: Some Facts Worth Knowing

Zacks
·
24 Jan

Siga Technologies Inc. (SIGA) Stock Dips While Market Gains: Key Facts

Zacks
·
18 Jan

Siga Technologies Inc. (SIGA) Advances But Underperforms Market: Key Facts

Zacks
·
16 Jan

Japan Approves SIGA Technologies Antiviral As First For Smallpox, Mpox

Benzinga
·
02 Jan

BRIEF-Tepoxx Approved In Japan For The Treatment Of Orthopoxviruses

Reuters
·
02 Jan

SIGA Technologies Says Japan's Pharmaceutical Regulator Approves its Antiviral Treatment for Smallpox, MPox, Cowpox

MT Newswires Live
·
02 Jan

Siga Technologies approved in Japan for treatment of orthopoxviruses

TIPRANKS
·
02 Jan

Tepoxx (Tecovirimat) Approved in Japan for the Treatment of Orthopoxviruses

THOMSON REUTERS
·
02 Jan

SIGA Technologies Inc - Japan Biotechno Pharma to Supply Tepoxx to National Stockpile

THOMSON REUTERS
·
02 Jan

Are Investors Undervaluing Siga Technologies (SIGA) Right Now?

Zacks
·
25 Dec 2024

Why Rumble Shares Are Trading Higher By Around 43%; Here Are 20 Stocks Moving Premarket

Benzinga
·
23 Dec 2024

Undiscovered Gems In The United States To Explore December 2024

Simply Wall St.
·
20 Dec 2024

Is Siga Technologies (SIGA) Stock Outpacing Its Medical Peers This Year?

Zacks
·
11 Dec 2024

BRIEF-Interim Results From Stomp Study Of Siga’S Tecovirimat In Treatment Of Mpox Announced

Reuters
·
11 Dec 2024